Resources for Canadian Healthcare Professionals and Patients
SPIKEVAX® (COVID-19 mRNA Vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in individuals 6 months of age and older.
The National Advisory Committee on Immunization (NACI) strongly recommends a dose of the new formulation of COVID-19 vaccine for previously vaccinated and unvaccinated individuals at increased risk of SARS-CoV-2 infection or severe COVID-19 disease, for example:
All Adults 65 years of age or older
Those 6 months of age and older who are:
Residents of long-term care homes and other congregate living settings
Individuals with underlying medical conditions that place them at higher risk of severe COVID-19, including children with complex health needs
Individuals who are pregnant
Individuals in or from First Nations, Métis and Inuit communities*
Members of racialized and other equity-deserving communities
People who provide essential community services
Click here for the full NACI statement on the use of COVID-19 vaccines during fall of 2024.
Please find helpful resources for SPIKEVAX below. Check back as we update with additional educational content as it becomes available.
0.1 mg/mL Drug Identification Number (DIN): 02541270
*Autonomous decisions should be made by Indigenous Peoples with the support of healthcare and public health partners in accordance with the United Nations Declaration on the Rights of Indigenous Peoples Act.
Healthcare Professionals Resources
Dosage, Administration, Storage, and Handling (DASH) - Sep 17, 2024
Product Monograph - Sep 17, 2024
Product Concerns
All designated vaccination sites need to maintain security around the storage of SPIKEVAX® COVID-19 mRNA Vaccine within their facilities.
Make sure that vials of SPIKEVAX® COVID-19 mRNA Vaccine arrive and are stored in their original packaging. If you suspect that the SPIKEVAX® COVID-19 mRNA Vaccine you have purchased may be counterfeit, if there are any irregularities with packaging, and/or with the arrival of the shipments, please contact us at 1‑866‑663‑3762 or visit www.modernatx.com, or report a complaint to Health Canada.
Vial Expiration Checker
Find the expiration date here for any vial of Moderna COVID-19 Vaccine through the LOT number of the vial
Reporting Adverse Events
Managing marketed health product-related side effects depends on healthcare professionals and patients reporting them. Any serious or unexpected side effects in patients receiving SPIKEVAX® COVID-19 mRNA Vaccine should be reported to your local Health Unit.
If a patient experiences a side effect following immunization, please complete the Adverse Events Following Immunization (AEFI) Form appropriate for your province/territory and send it to your local Health Unit.
In addition, you can report side effects to Moderna at Adverse Event Intake Portal